Loading insider details...
Beta
Latest Form 4 (Aug 21, 2026): Grant/Award of 44,964 AARD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Aardvark Therapeutics, Inc. (AARD) | Grant/Award | 44,964 | n/a |
| Jul 1, 2026 | Natera, Inc. (NTRA) | Grant/Award | 1,571 | n/a |
| Jun 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 4,500 | $96.2K |
| May 21, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 4,000 | n/a |
| May 15, 2026 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 31,250 | n/a |
| May 7, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 4,500 | $82.2K |
| May 4, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 9,750 | $66.5K |
| Apr 29, 2026 | Natera, Inc. (NTRA) | Grant/Award | 83 | n/a |
| Apr 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 8,000 | $143.5K |
| Apr 7, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 10,000 | $265.2K |